EJK-16282-31350

2 vaccinations 1 coded response 1 check-in 0 free-text entries 0 call cases

Sex: Male
Age at first dose: 0-4
ZIP prefix: 030 / NH
Registered: 2022-06-23

Relationship: Child or adolescent in my care
Guardian: DA4-25724-87420
Race: Asian
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-23
Registered in v-safe
2023-01-06
Dose 1 — Pfizer-BioNTech
2023-02-17
Dose 2 — Pfizer-BioNTech
2023-05-23
Survey response — 3 months, dose 2, dependent
MedDRA: Cough, Pyrexia — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-01-06	Pfizer-BioNTech	No
2	2023-02-17	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release